REQUEST A DEMO
Total
USD $0.00
Search more companies

Yunycom D.O.O. Beograd (Serbia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Yunycom D.O.O. Beograd Profile Updated: September 30, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Since July 1990, when it was established as a privately-owned company, YUNYCOM has been engaged in the import of medical devices and diagnostic materials produced by world leading manufacturers.
They import the required material used in biochemistry, hematology, transfusion, microbiology, phisical therapy, cardiology.
The stock list contains 9,000 different products. They cover the markets of Serbia, Montenegro and Republic of Srpska. Most advanced equipment produced by 35 world-renowned manufacturers is certified by highly educated managers and maintenance officers in specified fields (medicine, pharmacy, economics, electrical engineering, law…).

Headquarters
Bulevar Oslobodjenja 185
Belgrade; Belgrade;

Contact Details: Purchase the Yunycom D.O.O. Beograd report to view the information.

Website: http://www.yunycom.rs

Basic Information
Total Employees:
Purchase the Yunycom D.O.O. Beograd report to view the information.
Registered Capital:
Purchase the Yunycom D.O.O. Beograd report to view the information.
Financial Auditors:
Purchase the Yunycom D.O.O. Beograd report to view the information.
Incorporation Date:
July 10, 1990
Key Executives
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Yunycom D.O.O. Beograd report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RSD. Absolute financial data is included in the purchased report.
Net sales revenue
14.65%
Total operating revenue
13.39%
Operating profit (EBIT)
13.23%
EBITDA
13.34%
Net Profit (Loss) for the Period
20.75%
Total Assets
13.07%
Total Equity
9.41%
Operating Profit Margin (ROS)
-0.29%
Net Profit Margin
0.93%
Return on Equity (ROE)
3.09%
Debt/Equity
0.05%
Quick Ratio
-0.09%
Cash Ratio
-0.13%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?